References
- Elkayam U, Frishman W. Cardiovascular effects of phenothiazines. American Heart Journal 1980; 100: 397–401
- Kaplan H I, Sadock B J. Synopsis of psychiatry., 5th ed. Williams and Wilkins, Baltimore 1988; 492, Chap 31.1 General principles of psychopharmacology
- Fowler N O, McCall D, Chou T C, et al. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. American Journal of Cardiology 1976; 37: 223–30
- Kelly H G, Fay J E, Laverty S G. Thioridazine hydrochloride (Mellaril): its effect on the ECG and a report of two fatalities with ECG abnormalities. Canadian Medical Association Journal 1963; 89: 546–54
- Hollister L E, Kosek J C. Sudden death during treatment with phenothiazine derivatives. Journal of the American Medical Association 1965; 192: 93–6
- Moore M T, Book M H. Sudden death in phenothiazine therapy. Psychiatric Quarterly 1970; 44: 389–402
- Giles T D, Modlin R K. Death associated with ventricular arrhythmia and thioridazine hydrochloride. Journal of the American Medical Association 1968; 205: 108–10
- Alexander C S, Nino A. Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report. American Heart Journal 1969; 78: 757–69
- Reinert R E, Hermann D G. Unexplained death during chlorpromazine therapy. Journal of Nervous and Mental Disorders 1960; 131: 434–42
- Krikler D M, Curry P VL. Torsade de points, an atypical ventricular tachycardia. British Heart Journal 1976; 38: 117–20
- Schoonmaker R W, Osteen T, Greenfield J C. Thioridazine (Mellaril) induced ventricular tachycardia controlled with artificial pacemaker. Annals of Internal Medicine 1966; 65: 1076–8
- Leestma J E, Koenig K L. Sudden death and phenothiazines. Archives of General Psychiatry 1968; 18: 137–48
- Han J, Garcia De Jalon P D, Moe G K. Fibrillation threshold of premature ventricular responses. Circulation Research 1966; 18: 18–25
- Dietzman R H, Lillehei R C. The treatment of cardiogenic shock Part IV. The use of phenoxybenzamine and chlorpromazine. American Heart Journal 1968; 75: 136–8
- Greiner A C, Nicolson G A. Pigment deposition in viscera associated with prolonged chlorpromazine therapy. Canadian Medical Association Journal 1964; 91: 627–35
- Richardson H L, Graupner K I, Richardson M E. Intramyocardial lesions in patients dying suddenly and unexpectedly. Journal of the American Medical Association 1966; 195: 114–20
- Mehtonen O P, Aranko K, Malkonen L, Vapaatalo H. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scan-dinavica 1991; 1: 58–64
- Flugelman M Y, Tal A, Pollack S, et al. Psychotropic drugs and long QT syndromes: case reports. Journal of Clinical Psychiatry 1985; 46: 290–291
- McCreadie R G, Todd N, Livingston M, et al. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia. Acta Psychiatrica Scandinavica 1988; 78: 49–56